Подписаться
Chekhun V. F.
Chekhun V. F.
prof. medicine R.E. Kavetsky IEPOR
Подтвержден адрес электронной почты в домене onconet.kiev.ua
Название
Процитировано
Процитировано
Год
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
O Kovalchuk, J Filkowski, J Meservy, Y Ilnytskyy, VP Tryndyak, ...
Molecular cancer therapeutics 7 (7), 2152-2159, 2008
8072008
Иммунология злокачественного роста
НМ Бережная, ВФ Чехун
Наукова думка, 2005
2622005
Role of ferritin alterations in human breast cancer cells
SI Shpyleva, VP Tryndyak, O Kovalchuk, A Starlard-Davenport, ...
Breast cancer research and treatment 126, 63-71, 2011
2302011
MicroRNA-mediated drug resistance in breast cancer
KR Kutanzi, OV Yurchenko, FA Beland, VF Checkhun, IP Pogribny
Clinical epigenetics 2, 171-185, 2011
1982011
Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper-and hypomethylated targets
VF Chekhun, NY Lukyanova, O Kovalchuk, VP Tryndyak, IP Pogribny
Molecular cancer therapeutics 6 (3), 1089-1098, 2007
1512007
Система интерлейкинов и рак
НМ Бережная, ВФ Чехун
Киев: Диа, 2000
1452000
Long-term exposure to microwave radiation provokes cancer growth: evidences from radars and mobile communication systems
I Yakymenko, E Sidorik, S Kyrylenko, V Chekhun
1142011
Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells
VF Chekhun, GI Kulik, OV Yurchenko, VP Tryndyak, IN Todor, LS Luniv, ...
Cancer letters 231 (1), 87-93, 2006
1062006
Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin
VF Chekhun, NY Lukyanova, АP Burlaka, NA Bezdenezhnykh, ...
International journal of oncology 43 (5), 1481-1486, 2013
1012013
Synthesis and antiproliferative activity of conformationally restricted 1, 2, 3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer …
DV Demchuk, AV Samet, NB Chernysheva, VI Ushkarov, GA Stashina, ...
Bioorganic & medicinal chemistry 22 (2), 738-755, 2014
822014
Эозинофилы, базофилы и иммуноглобулин Е в противоопухолевой защите
НМ Бережная, ВФ Чехун, РИ Сепиашвили
Аллергология и иммунология 6 (1), 38-49, 2005
812005
Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity
S Daum, VF Chekhun, IN Todor, NY Lukianova, YV Shvets, L Sellner, ...
Journal of medicinal chemistry 58 (4), 2015-2024, 2015
802015
Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin
NY Lukyanova, NV Rusetskya, NA Tregubova, VF Chekhun
Experimental oncology, 2009
792009
The lipid content of cisplatin-and doxorubicin-resistant MCF-7 human breast cancer cells
IN Todor, NY Lukianova, VF Chekhun
Experimental oncology, 2012
772012
Роль генов р53 и bcl-2 в апоптозе и лекарственной резистентности опухолей
НЮ Лукьянова, ГИ Кулик, ВФ Чехун
Вопр. онкол 46 (2), 121-128, 2000
712000
MicroRNAs in normal and cancer cells: a new class of gene expression regulators
TV Bagnyukova, IP Pogribny, VF Chekhun
Інститут експериментальної патології, онкології і радіобіології ім. РЄ …, 2006
532006
Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy
NM Bereznaya, VF Chekhun
Experimental oncology, 2007
512007
СD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
SV Chekhun, TV Zadvorny, YO Tymovska, MF Anikusko, OE Novak, ...
Experimental oncology, 58-63, 2015
452015
Immunology of malignant growth
NM Berezhnaya, VF Chekhun
Kyiv: Naukova Dumka, 2005
402005
Nanocomposites of medicobiologic destination: reality and perspectives for oncology. Review
PP Gorbyk, VF Chekhun
Functional materials, 2012
372012
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20